Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 5/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.54 |
| ▸ | ALPI | P09923 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | XIAP | P98170 | 1/20 | 0.54 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.54 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.54 |
| ▸ | TPH1 | P17752 | 2/20 | 0.48 |
| ▸ | GRB2 | P62993 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | FYN | P06241 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Serine SCHEMBL9073599 | 0.91 | SLC7A5 (0.61) | SLC7A5PTPN1PTGS1ALPIPKM | |
| SCHEMBL2464010 | 0.88 | SLC7A5 (0.53) | SLC7A5PTPN1PTGS1ALPIPKM | |
| Phenylalanine SCHEMBL5608077 | 0.88 | SLC7A5 (0.69) | SLC7A5PTPN1PTGS1ALPIPKM | |
| Phenylalanine SCHEMBL5699042 | 0.88 | SLC7A5 (0.69) | SLC7A5PTPN1PTGS1ALPIPKM | |
| SCHEMBL1003560 | 0.88 | SLC7A5 (0.69) | SLC7A5PTPN1PTGS1ALPIPKM | |
| SCHEMBL60228 | 0.86 | SLC7A5 (0.73) | SLC7A5PTPN1PTGS1ALPIPKM | |
| SCHEMBL9120090 | 0.86 | SLC7A5 (0.54) | SLC7A5PTPN1PTGS1ALPIPKM | |
| SCHEMBL11676390 | 0.86 | SLC7A5 (0.73) | SLC7A5PTPN1PTGS1ALPIPKM | |
| SCHEMBL10978818 | 0.86 | SLC7A5 (0.73) | SLC7A5PTPN1PTGS1ALPIPKM | |
| SCHEMBL1667022 | 0.86 | SLC7A5 (0.73) | SLC7A5PTPN1PTGS1ALPIPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024047497-A1 | TREATMENTS FOR PRURIGO NODULARIS | Galderma Holding SA (CH) | 2024-03-07 | — | — | WO | disclosed |
| CN-115369461-A | Platinum group metal electroplating solution complexing agent composition for medical and electronic wearable equipment | 永星化工(上海)有限公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-114431342-A | Protein amino acid pet food for promoting development and detection method thereof | 弘煋科技(北京)有限公司 | 2022-05-06 | — | — | CN | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |
| EP-3443001-A2 | REGULATED BIOCIRCUIT SYSTEMS | Obsidian Therapeutics, Inc. (US) | 2019-02-20 | — | — | EP | disclosed |
| WO-2017180587-A2 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. (US) | 2017-10-19 | — | — | WO | disclosed |
| EP-3102611-A1 | HUMANIZED BETA-AMYLOID BINDING MOLECULES AND USES THEREOF | Cangene Corporation (CA) | 2016-12-14 | — | — | EP | disclosed |
| WO-2015113169-A1 | HUMANIZED BETA-AMYLOID BINDING MOLECULES AND USES THEREOF | CNJ HOLDINGS, INC. (CA) | 2015-08-06 | — | — | WO | disclosed |
| EP-2307051-A2 | NOTCH-BINDING AGENTS AND ANTAGONISTS AND METHODS OF USE THEREOF | OncoMed Pharmaceuticals, Inc. (US) | 2011-04-13 | — | — | EP | disclosed |
| WO-2010005566-A2 | NOTCH-BINDING AGENTS AND ANTAGONISTS AND METHODS OF USE THEREOF | ONCOMED PHARMACEUTICALS, INC. (US) | 2010-01-14 | — | — | WO | disclosed |
| US-20030166224-A1 | 18232, a novel dual specificity phosphatase and uses therefor | MILLENNIUM PHARMACEUTICALS, INC., A DELAWARE CORPORATION | 2003-09-04 | — | — | US | disclosed |
| WO-2001064911-A9 | 18232, A DUAL SPECIFICITY PHOSPHATASE | MILLENNIUM PHARM INC (US) | 2003-02-06 | — | — | WO | disclosed |
| EP-1259625-A2 | 18232, A DUAL SPECIFICITY PHOSPHATASE | Millennium Pharmaceuticals, Inc. (US) | 2002-11-27 | — | — | EP | disclosed |
| US-6420153-B1 | NUCLEOTIDE SEQUENCES CODING ENZYMATIC POLYPEPTIDES FOR USE IN THE DIAGNOSIS, TREATMENT AND PREVENTION OF BLOOD DISORDERS AND LEUKEMIAS | MILLENNIUM PHARMACEUTICALS, INC. | 2002-07-16 | — | — | US | disclosed |
| WO-2001064911-A2 | 18232, A DUAL SPECIFICITY PHOSPHATASE | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2001-09-07 | — | — | WO | disclosed |
| CN-1066331-C | Oral medicinal liquor prepared from Armilariella tabescens | WANG WENXIAN (CN) | 2001-05-30 | — | — | CN | disclosed |
| WO-2000049889-A1 | ANIMAL FEED SUPPLEMENT FOR THE NUTRITIONAL ENRICHMENT OF ANIMAL PRODUCE | BARTLETT GRAIN PTY. LTD. (AU) | 2000-08-31 | — | — | WO | disclosed |
| CN-1227501-A | Long-acting drugs and pharmaceutical compositions comprising them | YEDA RES & DEV (IL) | 1999-09-01 | — | — | CN | disclosed |
| CN-1217916-A | Oral medicinal liquor prepared from Armilariella tabescens | WANG WENXIAN (CN) | 1999-06-02 | — | — | CN | disclosed |
| WO-1998024432-A2 | USE OF INDOLINONE COMPOUNDS AS MODULATORS OF PROTEIN KINASES | SUGEN, INC. (US) | 1998-06-11 | — | — | WO | disclosed |